Literature DB >> 10090349

Blood pressure and the risk of complex arrhythmia in renal insufficiency, hemodialysis, and renal transplant patients.

J J de Lima1, M L Vieira, H F Lopes, C J Gruppi, C J Medeiros, L E Ianhez, E M Krieger.   

Abstract

Complex arrhythmia is frequent in hemodialysis patients but it is not clear if this is a consequence of dialysis or uremia or is secondary to the hemodynamic and cardiovascular alterations often associated with chronic renal failure. The incidence of complex ventricular arrhythmia (frequent multiform premature beats, couplets, and runs) in 31 subjects who had their uremic status recently corrected by renal transplant (Group 1) and in 23 predialysis (Group 2) and 73 hemodialysis (Group 3) chronic renal failure patients were studied with 24-h Holter monitoring. Patients were not receiving antiarrhythmic drugs or digitalis and significant coronary artery disease was excluded by clinical and noninvasive methods. Complex arrhythmia was two times more frequent in dialysis patients but the difference did not reach statistical significance (Group 1: 16%; Group 2: 17%; Group 3: 34%; chi2 4.9, P = .086). The stepwise model of logistic regression analysis identified systolic blood pressure (odds ratio 1.015, 95% confidence interval [CI] 1.001-1.027, P = .03) and left ventricular systolic dysfunction (odds ratio 7.04, 95% CI 1.3-36.7, P = .02) as the only factors that independently influenced the probability of complex arrhythmia. Age, gender, race, diabetes, smoking status, body mass index, diastolic blood pressure, serum creatinine, hematocrit, left ventricular mass index, and use of diuretics, beta-blockers, angiotensin converting enzyme (ACE) inhibitors, sympatolytics, and calcium channel blockers did not influence the occurrence of complex arrhythmia. The data indicate that blood pressure and myocardial dysfunction are more important determinants of complex arrhythmia than dialysis or uremia in chronic renal disease patients.

Entities:  

Mesh:

Year:  1999        PMID: 10090349     DOI: 10.1016/s0895-7061(98)00232-5

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  8 in total

Review 1.  Current understanding of optimal blood pressure goals in dialysis patients.

Authors:  Paul Light
Journal:  Curr Hypertens Rep       Date:  2006-10       Impact factor: 5.369

Review 2.  Treatment of hypertension in the hemodialysis patient: beneficial or not?

Authors:  M M Salem
Journal:  Curr Hypertens Rep       Date:  2000-10       Impact factor: 5.369

3.  Asymptomatic Ventricular Arrhythmia and Clinical Outcomes in Chronic Kidney Disease: A Pilot Study.

Authors:  Fabiana Oliveira Bastos Bonato; Renato Watanabe; Marcelo Montebello Lemos; José Luiz Cassiolato; Myles Wolf; Maria Eugênia Fernandes Canziani
Journal:  Cardiorenal Med       Date:  2016-10-28       Impact factor: 2.041

Review 4.  Cardiac metabolic remodelling in chronic kidney disease.

Authors:  Nikayla Patel; Muhammad Magdi Yaqoob; Dunja Aksentijevic
Journal:  Nat Rev Nephrol       Date:  2022-05-30       Impact factor: 42.439

5.  The association of ECG and echocardiographic abnormalities with sudden cardiac death in a dialysis patient cohort.

Authors:  Darren Green; James P Ritchie; Nik Abidin; David I New; Philip A Kalra
Journal:  J Nephrol       Date:  2013-12-12       Impact factor: 3.902

Review 6.  Mechanisms, Clinical Implications, and Treatment of Intradialytic Hypotension.

Authors:  Patrick B Reeves; Finnian R Mc Causland
Journal:  Clin J Am Soc Nephrol       Date:  2018-02-26       Impact factor: 8.237

7.  Predictors of Arrhythmic Events Detected by Implantable Loop Recorders in Renal Transplant Candidates.

Authors:  Rodrigo Tavares Silva; Martino Martinelli Filho; Giselle de Lima Peixoto; José Jayme Galvão de Lima; Sérgio Freitas de Siqueira; Roberto Costa; Luís Henrique Wolff Gowdak; Flávio Jota de Paula; Roberto Kalil Filho; José Antônio Franchini Ramires
Journal:  Arq Bras Cardiol       Date:  2015-09-04       Impact factor: 2.000

8.  Cigarette smoking: an important renal risk factor - far beyond carcinogenesis.

Authors:  S R Orth
Journal:  Tob Induc Dis       Date:  2002-06-15       Impact factor: 2.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.